_id
691305c5ccc777a4e85d7ab7
Ticker
JBPHF
Name
Jacobio Pharmaceuticals Group Co. Ltd.
Exchange
PINK
Address
Building 8, Beijing, China
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.jacobiopharma.com
Description
Jacobio Pharmaceuticals Group Co., Ltd., an investment holding company, engages in the in-house discovery and development of oncology therapies. Its clinical stage candidates include Glecirasib (JAB-21822), a KRAS G12C inhibitor under various stage studies for indications, such as NSCLC, PDAC, CRC, and other solid tumors; Sitneprotafib (JAB-3312), an SHP2 inhibitor that is in Phase III trials for NSCLC indication; JAB-23E73, a Pan-KRAS inhibitor for indications, including PDAC, CRC, and NSCLC; JAB-2485 Aurora A inhibitor, JAB-30355 p53 Y220C reactivator, JAB-BX102 CD73 mAb inhibitor, JAB-26766 PARP 7 inhibitor, and JAB-BX300 LIF inhibitor under trials for solid tumor indications; and JAB-24114, a glutamine-utilizing enzyme for solid tumors and hematological malignancies. The company also develops IND-enabling candidates comprising JAB-BX467, JAB-BX600, and JAB-BX700 for solid tumor indications. The company has a collaboration agreement with Merck for combination trials of cetuximab. Jacobio Pharmaceuticals Group Co., Ltd. was founded in 2015 and is headquartered in Beijing, China.
Last Close
0.9479
Volume
-
Current Price
0.8316
Change
0
Last Updated
2026-01-04T15:37:46.744Z
Image
-
Ipo Date
-
Market Cap
764391488
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.986
Sentiment Sources
1
Current Quarter
2023-06-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-
Interest Expense
-
Pretax Income
-
Net Income
-
Eps
-
Dividends Per Share
-
Shares Outstanding
787062780
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
1297908000
Short Term Investments
-
Receivables
35497000
Inventories
-
Total Current Assets
1333405000
Property Plant Equipment
230164000
Total Assets
1595002000
Payables
81902000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
332275000
Equity
1262727000
Bs_currency_symbol
USD
Depreciation
4978000
Change In Working Capital
-
Cash From Operations
-109880500
Capital Expenditures
17188000
Cash From Investing
85302000
Cash From Financing
94665000
Net Change In Cash
79623500
Cf_currency_symbol
USD
PE
-
PB
0.5226200057874743
ROE
-
ROA
-
FCF
-127068500
Fcf Percent
-
Piotroski FScore
0
Health Score
59
Deep Value Investing Score
6
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
2.5
Garp Investing Score
1.5
Growth Investing Score
0
Momentum Investing Score
2
Net Net Investing Score
6
Quality Investing Score
2
Value Investing Score
6
Quarters > 0 > quarter
2023-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
793562280
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1297908000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
35497000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1333405000
Quarters > 0 > balance Sheet > property Plant Equipment
230164000
Quarters > 0 > balance Sheet > total Assets
1595002000
Quarters > 0 > balance Sheet > payables
81902000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
332275000
Quarters > 0 > balance Sheet > equity
1262727000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-83140500
Quarters > 0 > cash Flow > depreciation
4978000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-109880500
Quarters > 0 > cash Flow > capital Expenditures
17188000
Quarters > 0 > cash Flow > cash From Investing
85302000
Quarters > 0 > cash Flow > cash From Financing
94665000
Quarters > 0 > cash Flow > net Change In Cash
79623500
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
0.5226200057874743
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-127068500
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
59
Quarters > 1 > quarter
2023-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
35497000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1333405000
Quarters > 1 > balance Sheet > property Plant Equipment
230164000
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
81902000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
202873000
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-83140500
Quarters > 1 > cash Flow > depreciation
4978000
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-109880500
Quarters > 1 > cash Flow > capital Expenditures
17188000
Quarters > 1 > cash Flow > cash From Investing
85302000
Quarters > 1 > cash Flow > cash From Financing
94665000
Quarters > 1 > cash Flow > net Change In Cash
79623500
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-127068500
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2022-12-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-
Quarters > 2 > income Statement > net Income
-
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
771462180
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
1283598000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1338747000
Quarters > 2 > balance Sheet > property Plant Equipment
205228000
Quarters > 2 > balance Sheet > total Assets
1574647000
Quarters > 2 > balance Sheet > payables
96551000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
292123000
Quarters > 2 > balance Sheet > equity
1282524000
Quarters > 2 > balance Sheet > currency_symbol
CNY
Quarters > 2 > cash Flow > net Income
-122018000
Quarters > 2 > cash Flow > depreciation
3693500
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-90296000
Quarters > 2 > cash Flow > capital Expenditures
6819000
Quarters > 2 > cash Flow > cash From Investing
-342309500
Quarters > 2 > cash Flow > cash From Financing
-3416000
Quarters > 2 > cash Flow > net Change In Cash
-417757500
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
0.5002229579235944
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-97115000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
59
Quarters > 3 > quarter
2022-09-30
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
-
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
-
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
0
Quarters > 3 > cash Flow > depreciation
3693500
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-90296000
Quarters > 3 > cash Flow > capital Expenditures
6819000
Quarters > 3 > cash Flow > cash From Investing
-342309500
Quarters > 3 > cash Flow > cash From Financing
-3416000
Quarters > 3 > cash Flow > net Change In Cash
-417757500
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-97115000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
45
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
155708000
Annuals > 0 > income Statement > cost Of Revenue
0
Annuals > 0 > income Statement > gross Profit
155708000
Annuals > 0 > income Statement > operating Expenses
358904000
Annuals > 0 > income Statement > operating Income
-203196000
Annuals > 0 > income Statement > interest Expense
8399000
Annuals > 0 > income Statement > pretax Income
-155709000
Annuals > 0 > income Statement > net Income
-155709000
Annuals > 0 > income Statement > eps
-0.1973944975984297
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
788821380
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-130.49811185038664
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
CNY
Annuals > 0 > balance Sheet > cash
1174539000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
7678000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1188614000
Annuals > 0 > balance Sheet > property Plant Equipment
151492000
Annuals > 0 > balance Sheet > total Assets
1359168000
Annuals > 0 > balance Sheet > payables
117960000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
16000000
Annuals > 0 > balance Sheet > total Liabilities
435988000
Annuals > 0 > balance Sheet > equity
923180000
Annuals > 0 > balance Sheet > currency_symbol
CNY
Annuals > 0 > cash Flow > net Income
-155709000
Annuals > 0 > cash Flow > depreciation
26458000
Annuals > 0 > cash Flow > change In Working Capital
77074000
Annuals > 0 > cash Flow > cash From Operations
-74120000
Annuals > 0 > cash Flow > capital Expenditures
12090000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
203385000
Annuals > 0 > cash Flow > currency_symbol
CNY
Annuals > 0 > ratios > PE
-0.1973944975984297
Annuals > 0 > ratios > PB
0.8099436579020342
Annuals > 0 > ratios > ROE
-16.866591563942027
Annuals > 0 > ratios > ROA
-11.456199675095352
Annuals > 0 > ratios > FCF
-86210000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.5536645515965782
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
63520000
Annuals > 1 > income Statement > cost Of Revenue
60317000
Annuals > 1 > income Statement > gross Profit
3203000
Annuals > 1 > income Statement > operating Expenses
471748000
Annuals > 1 > income Statement > operating Income
-408228000
Annuals > 1 > income Statement > interest Expense
8312000
Annuals > 1 > income Statement > pretax Income
-359119000
Annuals > 1 > income Statement > net Income
-359119000
Annuals > 1 > income Statement > eps
-0.45357334492883833
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
791755080
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-642.676322418136
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
CNY
Annuals > 1 > balance Sheet > cash
1143126000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
9339000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
1168410000
Annuals > 1 > balance Sheet > property Plant Equipment
219603000
Annuals > 1 > balance Sheet > total Assets
1460481000
Annuals > 1 > balance Sheet > payables
81191000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
0
Annuals > 1 > balance Sheet > total Liabilities
387110000
Annuals > 1 > balance Sheet > equity
1073371000
Annuals > 1 > balance Sheet > currency_symbol
CNY
Annuals > 1 > cash Flow > net Income
-359119000
Annuals > 1 > cash Flow > depreciation
25080000
Annuals > 1 > cash Flow > change In Working Capital
-13153000
Annuals > 1 > cash Flow > cash From Operations
-364199000
Annuals > 1 > cash Flow > capital Expenditures
38660000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-165922000
Annuals > 1 > cash Flow > currency_symbol
CNY
Annuals > 1 > ratios > PE
-0.45357334492883833
Annuals > 1 > ratios > PB
0.6992033885133845
Annuals > 1 > ratios > ROE
-33.45711780921974
Annuals > 1 > ratios > ROA
-24.589090854314435
Annuals > 1 > ratios > FCF
-402859000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-6.342238664987406
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
95746000
Annuals > 2 > income Statement > cost Of Revenue
83112000
Annuals > 2 > income Statement > gross Profit
12634000
Annuals > 2 > income Statement > operating Expenses
569456000
Annuals > 2 > income Statement > operating Income
-473710000
Annuals > 2 > income Statement > interest Expense
2270000
Annuals > 2 > income Statement > pretax Income
-371861000
Annuals > 2 > income Statement > net Income
-371861000
Annuals > 2 > income Statement > eps
-0.4820210369871923
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
771462180
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-355796000
Annuals > 2 > income Statement > operating Margin
-494.7569611263134
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
CNY
Annuals > 2 > balance Sheet > cash
1283598000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
1338747000
Annuals > 2 > balance Sheet > property Plant Equipment
205228000
Annuals > 2 > balance Sheet > total Assets
1574647000
Annuals > 2 > balance Sheet > payables
96551000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
292123000
Annuals > 2 > balance Sheet > equity
1282524000
Annuals > 2 > balance Sheet > currency_symbol
CNY
Annuals > 2 > cash Flow > net Income
-371861000
Annuals > 2 > cash Flow > depreciation
13795000
Annuals > 2 > cash Flow > change In Working Capital
131917000
Annuals > 2 > cash Flow > cash From Operations
-292418000
Annuals > 2 > cash Flow > capital Expenditures
16444000
Annuals > 2 > cash Flow > cash From Investing
-686322000
Annuals > 2 > cash Flow > cash From Financing
-9854000
Annuals > 2 > cash Flow > net Change In Cash
-902829000
Annuals > 2 > cash Flow > currency_symbol
CNY
Annuals > 2 > ratios > PE
-0.4820210369871923
Annuals > 2 > ratios > PB
0.5701795837130533
Annuals > 2 > ratios > ROE
-28.994467160068737
Annuals > 2 > ratios > ROA
-23.615515096399385
Annuals > 2 > ratios > FCF
-308862000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-3.2258475549892425
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
152809000
Annuals > 3 > income Statement > cost Of Revenue
139979000
Annuals > 3 > income Statement > gross Profit
12830000
Annuals > 3 > income Statement > operating Expenses
455133000
Annuals > 3 > income Statement > operating Income
-302324000
Annuals > 3 > income Statement > interest Expense
568000
Annuals > 3 > income Statement > pretax Income
-301187000
Annuals > 3 > income Statement > net Income
-301187000
Annuals > 3 > income Statement > eps
-0.3904105837048292
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
771462180
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-289828000
Annuals > 3 > income Statement > operating Margin
-197.84436780556118
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
1527204000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
97594000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
1639727000
Annuals > 3 > balance Sheet > property Plant Equipment
41772000
Annuals > 3 > balance Sheet > total Assets
1721834000
Annuals > 3 > balance Sheet > payables
51047000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
84746000
Annuals > 3 > balance Sheet > equity
1637088000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-301187000
Annuals > 3 > cash Flow > depreciation
10791000
Annuals > 3 > cash Flow > change In Working Capital
108400000
Annuals > 3 > cash Flow > cash From Operations
-147492000
Annuals > 3 > cash Flow > capital Expenditures
10106000
Annuals > 3 > cash Flow > cash From Investing
161667000
Annuals > 3 > cash Flow > cash From Financing
109057000
Annuals > 3 > cash Flow > net Change In Cash
96788000
Annuals > 3 > cash Flow > currency_symbol
CNY
Annuals > 3 > ratios > PE
-0.3904105837048292
Annuals > 3 > ratios > PB
0.44668887709274024
Annuals > 3 > ratios > ROE
-18.397728161222854
Annuals > 3 > ratios > ROA
-17.49222050441564
Annuals > 3 > ratios > FCF
-157598000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-1.0313397771073693
Annuals > 3 > health Score
33
Valuation > metrics > PB
0.5226200057874743
Valuation > final Score
70
Valuation > verdict
47.7% Undervalued
Profitability > final Score
50
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.2631408055739681
Risk > final Score
80
Risk > verdict
Low
Liquidity > metrics > Current Ratio
16.280493760836123
Liquidity > metrics > Quick Ratio
16.280493760836123
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
70
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
50
Prev Profitabilities > 2
50
Prev Risks > 0
50
Prev Risks > 1
80
Prev Risks > 2
50
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
50
Updated At
2026-01-20T22:04:05.160Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-17
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Jacobio Pharmaceuticals Group Co., Ltd., an investment holding company, engages in the in-house discovery and development of oncology therapies. Its clinical stage candidates include Glecirasib (JAB-21822), a KRAS G12C inhibitor under various stage studies for indications, such as NSCLC, PDAC, CRC, and other solid tumors; Sitneprotafib (JAB-3312), an SHP2 inhibitor that is in Phase III trials for NSCLC indication; JAB-23E73, a Pan-KRAS inhibitor for indications, including PDAC, CRC, and NSCLC; JAB-2485 Aurora A inhibitor, JAB-30355 p53 Y220C reactivator, JAB-BX102 CD73 mAb inhibitor, JAB-26766 PARP 7 inhibitor, and JAB-BX300 LIF inhibitor under trials for solid tumor indications; and JAB-24114, a glutamine-utilizing enzyme for solid tumors and hematological malignancies. The company also develops IND-enabling candidates comprising JAB-BX467, JAB-BX600, and JAB-BX700 for solid tumor indications. The company has a collaboration agreement with Merck for combination trials of cetuximab. Jacobio Pharmaceuticals Group Co., Ltd. was founded in 2015 and is headquartered in Beijing, China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2023-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Jacobio Pharmaceuticals Group Co. Ltd.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2023-06-30)
(Last Updated 2023-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.